Main Logo

Uromigos Live 2024 Perioperative UC Panel Part 3: Neoadjuvant ADC/PD-L1 Combinations, TAR-200, and Bladder-Sparing Approaches in MIBC

By Thomas Powles, MBBS, MRCP, MD, Andrea B. Apolo, MD, Shilpa Gupta, MD, Kala Sridhar, MD, Petros Grivas, MD, PhD - Last Updated: October 14, 2024

Dr. Powles continues to moderate the panel of Drs. Apolo, Grivas, Gupta, and Sridhar as they move into their discussion of combination therapy, the TAR-200 pretzel device, and other bladder-sparing approaches in MIBC.

Watch the final segment of this panel: Predicting the Future of Muscle Invasive Bladder Cancer After NIAGARA

Post Tags:Uromigos Live 2024: Focus on Bladder Cancer